Teva
May 18, 2012 at 12:58 | Source: Moneycontrol.com
Apr 03, 2012 at 11:22 | Source: Moneycontrol.com
Mar 01, 2012 at 19:12 | Source: CNBC-TV18
Mar 01, 2012 at 12:43 | Source:
Feb 03, 2012 at 16:56 | Source: Reuters
Videos »
Photos »
/ 
News across the web »
May 28, 2012 at 14:00 | Source: Business Week
May 25, 2012 at 09:31 | Source: DNA India
May 24, 2012 at 12:00 | Source: Business Week
May 22, 2012 at 21:47 | Source: Market Watch
May 21, 2012 at 01:46 | Source: Business Standard
Interact & exchange stock tips & market info »
Related News »
Teva Pharmaceuticals Industries Ltd. (TEVA) fell for a fourth week in New York, its longest losing streak since November, as the Israeli drug maker’s guidance cut spurred Piper Jaffray & Co. to recommend investors avoid the shares. American ...
May 28, 2012 at 06:13 | Source: Bloomberg
Teva Pharmaceutical Industries Ltd., the world's largest maker of generic drugs, said Thursday it is cutting its annual profit and sales forecasts. The Israeli company expects weaker sales of generic drugs, which bring in most of its revenue ...
May 24, 2012 at 15:36 | Source: Businessweek
Teva Pharmaceutical Industries Ltd. (TEVA) dropped to the lowest level this year in New York after Morgan Stanley said the Israeli company is losing its share of the U.S. generic drug market. Teva, which reported first-quarter sales that missed ...
May 23, 2012 at 23:51 | Source: Bloomberg
Generic drug giant Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has always been an exemplary model to be emulated, at least for other Israeli companies. The way it has grown and increased its value, continually swallowing up companies ...
May 29, 2012 at 07:52 | Source: Globes - Israel Business Arena
Teva Pharmaceutical Industries (TEVA) cut its 2012 revenue and sales guidance Thursday morning, but the stock nonetheless rose as it ended uncertainty about the outlook. Teva's new CEO, Jeremy Levin, declined to give a forecast when the generic-drug giant ...
May 24, 2012 at 15:22 | Source: Investors Business Daily
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) will enter the personalized medicine field, which will have high efficiency to cost ratios, albeit limited market segments, says Harel Finance analyst Steven Tepper following yesterday's speech ...
May 23, 2012 at 09:04 | Source: Globes - Israel Business Arena
Equities research analysts at Citigroup (NYSE: C) lowered their price target on shares of Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) to $49.00 in a research note issued to investors on Friday. The analysts wrote, “We lowered our 2012E EPS on TEVA ...
May 25, 2012 at 19:02 | Source: zolmax.com
Friday, May 11, 2012... Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) closed Thursday's trading session at $42.05. In the past year, the stock has hit a 52-week low of..... http://www.marketintelligencecenter.com/analyfav/1350686 Stocks Sink Under the ...
May 23, 2012 at 11:41 | Source: Market Intelligence Center
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA - News) today reported results for the quarter ended March 31, 2012. Net revenues of $5.1 billion, compared to $4.1 billion in the first quarter of 2011, an increase of 25%. Non-GAAP operating ...
May 28, 2012 at 16:43 | Source: Yahoo Finance
It was revealed on Thursday that Teva Pharmaceuticals (NASDAQ: TEVA) has cut its earnings and revenue forecast. Worryingly, the new numbers came in below analyst expectations. TEVA said that it is now expecting non-GAAP earnings per share between $5.30 and ...
May 24, 2012 at 15:29 | Source: Benzinga